
Yasho Industries Q1 FY27 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 1
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
2 of 3 growth signals are positive.
Full analysisRevenue guidance
Category 1- →Yasho Industries targets 30%-40% annual revenue growth over the next few years (Page 4).
- →Growth is primarily driven by export markets, which currently contribute ~69% of revenue, expected to stabilize around 70%-75% export share (Pages 7, 18-19).
- →Utilization is expected to ramp up from 60%-65% currently to 75% in FY27, supporting volume growth (Pages 12, 18-19).
- →New capacity at Pakhajan facility's Phase 1 to be operational from Q1 FY28, with revenue potential of Rs. 100 crores in FY28, not included in FY27 guidance (Pages 18-19).
- →Product mix improvement and new specialty products contribute to growth and better margins (Pages 14-15).
- →Focus on long-term customer contracts reduces volatility and supports stable margin and volume growth (Pages 13-14).
- →Expansion into Asian and African markets is underway, expected to contribute to export growth (Pages 7, 18).
Margin guidance
Category 3- →Yasho Industries targets 30%-40% annual revenue growth over the next few years, driven mainly by export markets and new product commercialization.
- →Margins are expected to be maintained at current levels (~24%) for FY27, supported by improved product mix, higher capacity utilization (~75% targeted), and better operating leverage.
- →The company expects sustained EBITDA margins due to long-term supply contracts with marquee customers rather than spot pricing.
- →New product lines launched over the last 18-24 months contribute about 30% of revenue and are expected to drive future growth.
- →CAPEX of Rs. 250 crores over FY27 towards new manufacturing facilities aims to support scaling operations with expected 2.5x revenue potential on CAPEX.
- →Improving net debt/EBITDA ratio (1.86x in Q1 FY27 vs. 3.75x prior) reflects stronger operating earnings and disciplined financial management.
- →Overall, Yasho aims for sustainable profit growth supported by capacity expansion, product innovation, and global market penetration.
3 more insights locked — sign up free to unlock
Fundraise plans
- →Yasho Industries Limited plans to raise approximately Rs. 100 crores through borrowings (debt) during FY27 to fund its expansion and capital expenditure.
- →No mention of any current or planned equity fundraising was noted in the document.
- →The company is increasing its FY27 capital expenditure plan from Rs. 125 crores to Rs. 250 crores primarily to construct two new production buildings at the Pakhajan facility.
- →The financial leverage has improved, with net debt to EBITDA ratio reducing from 3.75x at FY26 end to 1.86x as of June 30, 2026, supported by better operating earnings and profitability.
Order book
Capex plans
Yes- →Yasho Industries revised FY27 CAPEX guidance from Rs. 125 crores to Rs. 250 crores.
- →The investment will be directed towards constructing two new production buildings at the Pakhajan facility.
- →These buildings will manufacture several high-potential products developed through R&D efforts.
- →The first phase (Rs. 100 crores) is expected to come online by Q1 FY28; the second phase (Rs. 150 crores) by Q4 FY28.
- →The total revenue potential from this CAPEX is expected to be 2.5x the invested amount.
- →About 65% of the Rs. 250 crores CAPEX is already booked with customers.
- →The new capacity is anticipated to contribute incremental revenue starting FY28, with a target utilization of around 70%-75%.
- →The company also has ongoing projects aligned with customers' needs to support sustained growth.
How does Yasho Industries rank vs peers in Chemicals & Petrochemicals?
Pro featureSee full Chemicals & Petrochemicals sector rankings
How does Yasho Industries rank in Chemicals & Petrochemicals?
Compare Yasho Industries against every Chemicals & Petrochemicals company (Q1 FY27) on revenue, margins and earnings-call signals.